vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and JOINT Corp (JYNT). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $15.2M, roughly 1.3× JOINT Corp). JOINT Corp runs the higher net margin — 6.5% vs -6.8%, a 13.3% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 3.1%). JOINT Corp produced more free cash flow last quarter ($334.7K vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -28.6%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
APYX vs JYNT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $15.2M |
| Net Profit | $-1.3M | $991.1K |
| Gross Margin | 62.6% | 81.4% |
| Operating Margin | 0.1% | 4.9% |
| Net Margin | -6.8% | 6.5% |
| Revenue YoY | 34.7% | 3.1% |
| Net Profit YoY | 71.9% | 5510.5% |
| EPS (diluted) | — | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $15.2M | ||
| Q3 25 | $12.9M | $13.4M | ||
| Q2 25 | $11.4M | $13.3M | ||
| Q1 25 | $9.4M | $13.1M | ||
| Q4 24 | $14.2M | $14.7M | ||
| Q3 24 | $11.5M | $30.2M | ||
| Q2 24 | $12.1M | $30.3M | ||
| Q1 24 | $10.2M | $29.7M |
| Q4 25 | $-1.3M | $991.1K | ||
| Q3 25 | $-2.0M | $855.0K | ||
| Q2 25 | $-3.8M | $93.4K | ||
| Q1 25 | $-4.2M | $967.8K | ||
| Q4 24 | $-4.6M | $17.7K | ||
| Q3 24 | $-4.7M | $-3.2M | ||
| Q2 24 | $-6.6M | $-3.6M | ||
| Q1 24 | $-7.6M | $947.0K |
| Q4 25 | 62.6% | 81.4% | ||
| Q3 25 | 64.4% | 80.1% | ||
| Q2 25 | 62.3% | 79.1% | ||
| Q1 25 | 60.1% | 77.3% | ||
| Q4 24 | 63.0% | 78.4% | ||
| Q3 24 | 60.5% | 90.7% | ||
| Q2 24 | 61.7% | 90.7% | ||
| Q1 24 | 58.1% | 90.9% |
| Q4 25 | 0.1% | 4.9% | ||
| Q3 25 | -6.5% | 1.2% | ||
| Q2 25 | -22.6% | -8.6% | ||
| Q1 25 | -32.4% | -5.2% | ||
| Q4 24 | -21.4% | 5.5% | ||
| Q3 24 | -31.6% | -1.6% | ||
| Q2 24 | -45.7% | -5.9% | ||
| Q1 24 | -64.6% | -1.4% |
| Q4 25 | -6.8% | 6.5% | ||
| Q3 25 | -15.4% | 6.4% | ||
| Q2 25 | -33.2% | 0.7% | ||
| Q1 25 | -44.0% | 7.4% | ||
| Q4 24 | -32.5% | 0.1% | ||
| Q3 24 | -40.9% | -10.5% | ||
| Q2 24 | -54.0% | -11.9% | ||
| Q1 24 | -74.0% | 3.2% |
| Q4 25 | — | $0.06 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | $0.01 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | $-0.21 | ||
| Q2 24 | $-0.19 | $-0.24 | ||
| Q1 24 | $-0.22 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $23.6M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $15.1M |
| Total Assets | $66.8M | $61.0M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $23.6M | ||
| Q3 25 | $25.1M | $29.7M | ||
| Q2 25 | $29.3M | $29.8M | ||
| Q1 25 | $31.0M | $21.9M | ||
| Q4 24 | $31.7M | $25.1M | ||
| Q3 24 | $28.0M | $20.7M | ||
| Q2 24 | $32.7M | $17.5M | ||
| Q1 24 | $37.3M | $18.7M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $15.1M | ||
| Q3 25 | $5.8M | $22.7M | ||
| Q2 25 | $7.3M | $23.2M | ||
| Q1 25 | $10.5M | $22.8M | ||
| Q4 24 | $14.2M | $20.7M | ||
| Q3 24 | $11.0M | $20.5M | ||
| Q2 24 | $14.7M | $23.2M | ||
| Q1 24 | $20.3M | $26.2M |
| Q4 25 | $66.8M | $61.0M | ||
| Q3 25 | $57.4M | $69.4M | ||
| Q2 25 | $58.2M | $73.2M | ||
| Q1 25 | $60.2M | $80.1M | ||
| Q4 24 | $64.8M | $83.2M | ||
| Q3 24 | $60.7M | $79.6M | ||
| Q2 24 | $65.4M | $82.4M | ||
| Q1 24 | $70.7M | $85.7M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $1.8M |
| Free Cash FlowOCF − Capex | $-2.8M | $334.7K |
| FCF MarginFCF / Revenue | -14.6% | 2.2% |
| Capex IntensityCapex / Revenue | 1.4% | 9.9% |
| Cash ConversionOCF / Net Profit | — | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-1.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $1.8M | ||
| Q3 25 | $-3.5M | $1.8M | ||
| Q2 25 | $-1.2M | $868.6K | ||
| Q1 25 | $-702.0K | $-3.7M | ||
| Q4 24 | $-2.9M | $9.4M | ||
| Q3 24 | $-4.4M | $3.4M | ||
| Q2 24 | $-4.3M | $-973.5K | ||
| Q1 24 | $-6.3M | $2.8M |
| Q4 25 | $-2.8M | $334.7K | ||
| Q3 25 | $-4.1M | $1.5M | ||
| Q2 25 | $-1.5M | $363.6K | ||
| Q1 25 | $-757.0K | $-4.0M | ||
| Q4 24 | $-3.2M | $8.2M | ||
| Q3 24 | $-4.6M | $3.2M | ||
| Q2 24 | $-4.6M | $-1.2M | ||
| Q1 24 | $-6.4M | $2.4M |
| Q4 25 | -14.6% | 2.2% | ||
| Q3 25 | -31.5% | 10.9% | ||
| Q2 25 | -13.2% | 2.7% | ||
| Q1 25 | -8.0% | -30.8% | ||
| Q4 24 | -22.4% | 55.9% | ||
| Q3 24 | -40.0% | 10.6% | ||
| Q2 24 | -38.0% | -4.1% | ||
| Q1 24 | -62.2% | 8.1% |
| Q4 25 | 1.4% | 9.9% | ||
| Q3 25 | 4.0% | 2.4% | ||
| Q2 25 | 2.3% | 3.8% | ||
| Q1 25 | 0.6% | 2.5% | ||
| Q4 24 | 1.7% | 8.1% | ||
| Q3 24 | 1.3% | 0.8% | ||
| Q2 24 | 2.4% | 0.9% | ||
| Q1 24 | 0.3% | 1.3% |
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 2.07× | ||
| Q2 25 | — | 9.30× | ||
| Q1 25 | — | -3.82× | ||
| Q4 24 | — | 532.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
